EGFR and adenocarcinoma: This possibly be explained by the differences in pathological features and mechanism of progression between adenocarcinoma and squamous carcinoma.15 EGFR mutations are more prevalent in adenocarcinomas than in squamous carcinoma, which may be related to the differences in cell type and differentiation status between the two types of NSCLC.